Lu and colleagues have demonstrated in a recent study that the use of NaHS, a hydrophilic fast H2S release, could suppress the formation of atherosclerosis via the degradation of TGF-β, as well as the reduction of smad3 phosphorylation. The gene discussed is TGFB1; the disease is atherosclerosis.